Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

Delayed Data
As of Apr 27
 +0.05 / +1.16%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for ImmunoGen Inc have a median target of 5.50, with a high estimate of 8.00 and a low estimate of 1.40. The median estimate represents a +26.44% increase from the last price of 4.35.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in ImmunoGen Inc. This rating has held steady since April, when it was upgraded from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 31

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 30.64%
Growthannually 14.19%


Growthquarterly 109.81%
Growthannually 10.57%
Key to the earnings and sales forecast charts.